Stephan Laggai
Saarbruecken, SL 66123, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Alterations in the hepatocyte epigenetic landscape in steatosis.
Journal: Epigenetics & chromatin
Published: March 19, 2023
First Small-Molecule Inhibitors Targeting the RNA-Binding Protein IGF2BP2/IMP2 for Cancer Therapy.
Journal: ACS chemical biology
Published: January 13, 2022
The mRNA-binding Protein TTP/ZFP36 in Hepatocarcinogenesis and Hepatocellular Carcinoma.
Journal: Cancers
Published: October 13, 2019
Hepatocellular Carcinoma and Nuclear Paraspeckles: Induction in Chemoresistance and Prediction for Poor Survival.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: June 30, 2018
Lack of Kupffer cell depletion in diethylnitrosamine-induced hepatic inflammation.
Journal: Journal of hepatology
Published: June 15, 2018
IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.
Journal: Oncotarget
Published: January 04, 2017
Corrigendum: Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation.
Journal: Frontiers in physiology
Published: July 06, 2016
Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation.
Journal: Frontiers in physiology
Published: October 26, 2015
IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype.
Journal: Cell death & disease
Published: April 27, 2015
Hepatic hepcidin expression is decreased in cirrhosis and HCC.
Journal: Journal of hepatology
Published: October 13, 2014
Last Updated: 09/26/2026